DE69718018D1 - Materialien und methoden zur diagnose und behandlung von diabetes und fettleibigkeit - Google Patents

Materialien und methoden zur diagnose und behandlung von diabetes und fettleibigkeit

Info

Publication number
DE69718018D1
DE69718018D1 DE69718018T DE69718018T DE69718018D1 DE 69718018 D1 DE69718018 D1 DE 69718018D1 DE 69718018 T DE69718018 T DE 69718018T DE 69718018 T DE69718018 T DE 69718018T DE 69718018 D1 DE69718018 D1 DE 69718018D1
Authority
DE
Germany
Prior art keywords
obesity
diabetes
diagnosis
treatment
materials
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69718018T
Other languages
English (en)
Other versions
DE69718018T2 (de
Inventor
William Rademacher
Patricia Mclean
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rodaris Pharmaceuticals Ltd
Original Assignee
Rodaris Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rodaris Pharmaceuticals Ltd filed Critical Rodaris Pharmaceuticals Ltd
Publication of DE69718018D1 publication Critical patent/DE69718018D1/de
Application granted granted Critical
Publication of DE69718018T2 publication Critical patent/DE69718018T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
DE69718018T 1996-09-11 1997-09-11 Materialien und methoden zur diagnose und behandlung von diabetes und fettleibigkeit Expired - Fee Related DE69718018T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9618934.5A GB9618934D0 (en) 1996-09-11 1996-09-11 Inositol phosphoglycans for therapeutic use in the treatment of diabetes and obesity
PCT/GB1997/002440 WO1998011435A1 (en) 1996-09-11 1997-09-11 Materials and methods relating to the diagnosis and treatment of diabetes and obesity

Publications (2)

Publication Number Publication Date
DE69718018D1 true DE69718018D1 (de) 2003-01-30
DE69718018T2 DE69718018T2 (de) 2003-11-06

Family

ID=10799742

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69718018T Expired - Fee Related DE69718018T2 (de) 1996-09-11 1997-09-11 Materialien und methoden zur diagnose und behandlung von diabetes und fettleibigkeit

Country Status (12)

Country Link
US (2) US6716592B1 (de)
EP (1) EP0925503B1 (de)
JP (1) JP2001505658A (de)
CN (1) CN1234118A (de)
AU (1) AU722425B2 (de)
BR (1) BR9711753A (de)
CA (1) CA2264829A1 (de)
DE (1) DE69718018T2 (de)
ES (1) ES2189970T3 (de)
GB (1) GB9618934D0 (de)
IL (1) IL128894A0 (de)
WO (1) WO1998011435A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9618930D0 (en) * 1996-09-11 1996-10-23 Univ London Metal containing carbohydrates from human tissue which regulate lipogenic activity
GB9801899D0 (en) * 1998-01-29 1998-03-25 Univ London Neurotrophic properties of ipgs analogues
CA2321113A1 (en) * 1998-03-18 1999-09-23 Thomas William Rademacher Anti-inositolphosphoglycan monoclonal antibodies
GB9805771D0 (en) * 1998-03-18 1998-05-13 Hoeft Rademacher Limited Materials and methods relating to screening for inositolphosphoglycan mimetics
US20040192586A1 (en) * 1998-03-18 2004-09-30 Rodaris Pharmaceuticals Limited Materials and methods relating to anti-inositolphosphoglycan antibodies
GB9806645D0 (en) * 1998-03-27 1998-05-27 Univ London Materials and methods relating to the treatment of conditions involving mast cells,basophils and eosinophils
GB9814039D0 (en) * 1998-06-29 1998-08-26 Univ London Materials and methods relating to the prevention or treatment of ischaemia-reperfusion injury
GB9828560D0 (en) * 1998-12-23 1999-02-17 Rademacher Group Limited Substances from porcine tissue
US6716826B2 (en) 2000-05-12 2004-04-06 Rodaris Pharmaceuticals Limited Compounds and their uses
US6939857B2 (en) 2000-05-12 2005-09-06 Rodaris Pharmaceuticals Limited Compounds and their uses
US6759390B2 (en) 2000-05-12 2004-07-06 Manuel Martin-Lomas Compounds and their uses
EP1295122A2 (de) * 2000-05-12 2003-03-26 Rodaris Pharmaceuticals Limited Ipg-assay
US6953781B2 (en) 2000-05-12 2005-10-11 Rodaris Pharmaceuticals Limited Compounds and their uses
WO2005094200A2 (en) 2003-06-20 2005-10-13 University Of Florida Biomarkers for differentiating between type 2 and type 2 diabetes
US20100168218A1 (en) * 2005-07-26 2010-07-01 Kuhajda Francis P Method of reducing food intake
JP2007063225A (ja) * 2005-09-01 2007-03-15 Takeda Chem Ind Ltd イミダゾピリジン化合物
US20070197532A1 (en) * 2005-11-18 2007-08-23 Cao Sheldon X Glucokinase activators
WO2007104034A2 (en) 2006-03-08 2007-09-13 Takeda San Diego, Inc. Glucokinase activators
US8008332B2 (en) * 2006-05-31 2011-08-30 Takeda San Diego, Inc. Substituted indazoles as glucokinase activators
WO2008079787A2 (en) 2006-12-20 2008-07-03 Takeda San Diego, Inc. Glucokinase activators
US8173645B2 (en) * 2007-03-21 2012-05-08 Takeda San Diego, Inc. Glucokinase activators
US20080241745A1 (en) * 2007-03-29 2008-10-02 Fujifilm Corporation Negative resist composition and pattern forming method using the same
WO2009123597A1 (en) * 2008-04-04 2009-10-08 Robert Shorr Pharmaceutical composition
WO2010132447A2 (en) 2009-05-11 2010-11-18 Diabetomics, Llc Methods for detecting pre-diabetes and diabetes using differential protein glycosylation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5668695A (en) * 1979-11-10 1981-06-09 Sankyo Co Ltd Enzyme inhibitor griseolic acid and its preparation
US5183764A (en) 1989-03-08 1993-02-02 University Of Virginia Alumni Patents Foundation Quantitative analysis for diabetic condition predictor involving chiro-inositol
US5122603A (en) 1989-03-08 1992-06-16 The University Of Virginia Alumni Patents Foundation Purified insulin mediators and purification process for same
US5750348A (en) 1989-03-08 1998-05-12 The University Of Virginia Patents Foundation Method for detecting insulin resistance
US5427956A (en) 1989-03-08 1995-06-27 The University Of Virginia Patent Foundation Quantitative analysis for diabetic condition predictor
YU66892A (sh) 1991-08-20 1995-10-24 Hoechst Ag. Fosfoinositolglikan - peptid sa delovanjem kao insulin
GB9505658D0 (en) 1995-03-21 1995-05-10 Univ London Hormone and growth factor mimetics

Also Published As

Publication number Publication date
US20040063156A1 (en) 2004-04-01
AU4130497A (en) 1998-04-02
WO1998011435A1 (en) 1998-03-19
GB9618934D0 (en) 1996-10-23
DE69718018T2 (de) 2003-11-06
EP0925503A1 (de) 1999-06-30
IL128894A0 (en) 2000-01-31
JP2001505658A (ja) 2001-04-24
ES2189970T3 (es) 2003-07-16
CN1234118A (zh) 1999-11-03
EP0925503B1 (de) 2002-12-18
BR9711753A (pt) 2000-01-18
US6716592B1 (en) 2004-04-06
AU722425B2 (en) 2000-08-03
CA2264829A1 (en) 1998-03-19

Similar Documents

Publication Publication Date Title
DE69718018T2 (de) Materialien und methoden zur diagnose und behandlung von diabetes und fettleibigkeit
DE69725339D1 (de) Vorrichtung zur diagnose und behandlung von arrhythmien
DE69720058D1 (de) Vorrichtung für diagnose und behandlung von arrhytmien
DE69726195D1 (de) Vorrichtung für diagnose und behandlung von arrhytmien
DE69334246D1 (de) Verbesserte reagentien und methoden zur diagnose und behandlung von diabetes und stiff man syndrome
DE69626227D1 (de) Hierarchisches regelbasiertes system zur diagnose und behandlung von arrythmien
DE60108230D1 (de) Vorrichtung für diagnose und behandlung von arrhytmien
DE69715631T2 (de) Antikonvulsive sulfamatderivate zur behandlung von fettleibigkeit
DE69622509D1 (de) Verfahren zur Behandlung von Abgasen und Faulwasser
DE69934112D1 (de) Implantierbarer gewebeverschluss und system zur behandlung gastroösophagischen rückflusses
DE69529053D1 (de) Verfahren und gerät zur ozonbehandlung von böden zum töten lebender organismen
DE69622074T2 (de) Cystin-Silikon-Copolymere und deren Verwendung zur Behandlung von keratinischen Materialien
DE69531743D1 (de) System und verfahren zur diagnose von krankheiten an lebendem gewebe
DE69925266D1 (de) Verfahren und gerät zur behandlung von herzarhythmie
ATE275383T1 (de) Oxadisäuren und verwandte verbindungen zur behandlung von hautstörungen
DE69823459D1 (de) Herzbehandlungssystem zur Feststellung und Behandlung von Herzversagen
DE59410094D1 (de) Vorrichtung zur behandlung von biologischem gewebe und körperkonkrementen
DE69829921D1 (de) Vorrichtung zur Behandlung von Körpergewebe
DE69734531D1 (de) Beeinflussung von nitrosativem und oxidativem stress zur behandlung einer krankheit
DE69839093D1 (de) System zur behandlung von blut und verfahren zur optischen bestimmung des volumens der im plasma enthaltenen blutplättchen
ATE311876T1 (de) Hochselektive butyrylcholinesterase inhibitoren zur behandlung und zur diagnose von demenz und alzheimers krankheit
DE69015830T2 (de) Gerät zur Behandlung einer Flüssigkeit und Methode für den Antrieb.
DE820303T1 (de) p277 PEPTIDANALOGE, PHARMAZEUTISCHE ZUSAMMENSTELLUNG DAVON ZUR BEHANDLUNG UND DIAGNOSE VON DIABETES
DE69717707D1 (de) Verfahren zur Behandlung von Aussen- und Innenoberflächen von nichtleitenden porösen Materialien
DE69727240D1 (de) Kombinationen enthaltend vx478, zidovudin und 3tc zur behandlung von hiv

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee